APA

Morton C. A., Dominicus R., Radny P., Dirschka T., Hauschild A., Reinhold U., Aschoff R., Ulrich M., Keohane S., Ekanayake-Bohlig S., Ibbotson S., Ostendorf R., Berking C., Gröne D., Schulze H. J., Ockenfels H. M., Jasnoch V., Kurzen H., Sebastian M., Stege H., Staubach P., Gupta G., Hübinger F., Ziabreva I., Schmitz B., Gertzmann A., Lübbert H. & Szeimies R. (20191024). A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy. : The British journal of dermatology.

Chicago

Morton C A, Dominicus R, Radny P, Dirschka T, Hauschild A, Reinhold U, Aschoff R, Ulrich M, Keohane S, Ekanayake-Bohlig S, Ibbotson S, Ostendorf R, Berking C, Gröne D, Schulze H J, Ockenfels H M, Jasnoch V, Kurzen H, Sebastian M, Stege H, Staubach P, Gupta G, Hübinger F, Ziabreva I, Schmitz B, Gertzmann A, Lübbert H and Szeimies R-M. 20191024. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy. : The British journal of dermatology.

Harvard

Morton C. A., Dominicus R., Radny P., Dirschka T., Hauschild A., Reinhold U., Aschoff R., Ulrich M., Keohane S., Ekanayake-Bohlig S., Ibbotson S., Ostendorf R., Berking C., Gröne D., Schulze H. J., Ockenfels H. M., Jasnoch V., Kurzen H., Sebastian M., Stege H., Staubach P., Gupta G., Hübinger F., Ziabreva I., Schmitz B., Gertzmann A., Lübbert H. and Szeimies R. (20191024). A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy. : The British journal of dermatology.

MLA

Morton C A, Dominicus R, Radny P, Dirschka T, Hauschild A, Reinhold U, Aschoff R, Ulrich M, Keohane S, Ekanayake-Bohlig S, Ibbotson S, Ostendorf R, Berking C, Gröne D, Schulze H J, Ockenfels H M, Jasnoch V, Kurzen H, Sebastian M, Stege H, Staubach P, Gupta G, Hübinger F, Ziabreva I, Schmitz B, Gertzmann A, Lübbert H and Szeimies R-M. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy. : The British journal of dermatology. 20191024.